The biological plausibility of AOD9604s cartilage-regenerating effects is further supported by insights from conditions such as acromegaly, where excess GH leads to abnormally thick cartilage due to elevated local IGF-1 production
Most users inject on the same day each week to maintain consistent drug levels
Shared Risk Factors Aging and reduced absorption capacity Sedentary indoor lifestyle Limited sun Vegetarian or restrictive diets Gastrointestinal disorders (gastritis, IBS, celiac disease) Long-term use of proton pump inhibitors or metformin And when both are low, the effects compound
Theoretical and Class-Level Risks These have not been confirmed in cagrilintide trials but are flagged because they appear in related amylin or GLP-1 class data: pancreatitis, gallbladder disease, severe hypoglycemia (mainly when combined with insulin or sulfonylureas), and acute kidney injury secondary to dehydration from severe nausea or vomiting
it is a memorable label, not a medical claim
